News | March 18, 2023
Eiko LifeSciences to acquire 5% stake in Vivacious Pharmatex
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
The objective of launching these products at AAHAR is to create awareness on the consumption of protein based products
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
A funding to expand operations and provide better patient care
Subscribe To Our Newsletter & Stay Updated
